Jorgensen JOL - Search Results

1

Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer.

Kopchick JJ, Basu R, Berryman DE, Jorgensen JOL, Johannsson G, Puri V. Kopchick JJ, et al. Among authors: jorgensen jol. Nat Rev Endocrinol. 2022 Sep;18(9):558-573. doi: 10.1038/s41574-022-00702-6. Epub 2022 Jun 24. Nat Rev Endocrinol. 2022. PMID: 35750929 Free PMC article. Review.

2

Plasma ghrelin levels during exercise in healthy subjects and in growth hormone-deficient patients.

Dall R, Kanaley J, Hansen TK, Møller N, Christiansen JS, Hosoda H, Kangawa K, Jørgensen JO. Dall R, et al. Eur J Endocrinol. 2002 Jul;147(1):65-70. doi: 10.1530/eje.0.1470065. Eur J Endocrinol. 2002. PMID: 12088921

3

Effects of lowering circulating free fatty acid levels on protein metabolism in adult growth hormone deficient patients.

Nielsen S, Jørgensen JO, Hartmund T, Nørrelund H, Nair KS, Christiansen JS, Møller N. Nielsen S, et al. Growth Horm IGF Res. 2002 Dec;12(6):425-33. doi: 10.1016/s1096-6374(02)00119-3. Growth Horm IGF Res. 2002. PMID: 12423628 Clinical Trial.

4

Continuation of growth hormone therapy versus placebo in transition-phase patients with growth hormone deficiency: impact on body composition, insulin sensitivity, and thyroid function.

Jørgensen JO, Nørrelund H, Vahl N, Juul A, Skakkebaek NE, Christiansen JS. Jørgensen JO, et al. J Pediatr Endocrinol Metab. 2002 Dec;15 Suppl 5:1355-60. J Pediatr Endocrinol Metab. 2002. PMID: 12510991 Clinical Trial.

5

Growth hormone receptor expression and function in pituitary adenomas.

Clausen LR, Kristiansen MT, Rasmussen LM, Billestrup N, Blaabjerg O, Ledet T, Jørgensen JO. Clausen LR, et al. Clin Endocrinol (Oxf). 2004 May;60(5):576-83. doi: 10.1111/j.1365-2265.2004.02022.x. Clin Endocrinol (Oxf). 2004. PMID: 15104560

6

Growth hormone and glucose homeostasis.

Jørgensen JO, Krag M, Jessen N, Nørrelund H, Vestergaard ET, Møller N, Christiansen JS. Jørgensen JO, et al. Horm Res. 2004;62 Suppl 3:51-5. doi: 10.1159/000080499. Horm Res. 2004. PMID: 15539799 Review.

7

Incidence of GH deficiency - a nationwide study.

Stochholm K, Gravholt CH, Laursen T, Jørgensen JO, Laurberg P, Andersen M, Kristensen LØ, Feldt-Rasmussen U, Christiansen JS, Frydenberg M, Green A. Stochholm K, et al. Eur J Endocrinol. 2006 Jul;155(1):61-71. doi: 10.1530/eje.1.02191. Eur J Endocrinol. 2006. PMID: 16793951

8

Hypopituitarism and mortality in pituitary adenoma.

Lindholm J, Nielsen EH, Bjerre P, Christiansen JS, Hagen C, Juul S, Jørgensen J, Kruse A, Laurberg P, Stochholm K. Lindholm J, et al. Clin Endocrinol (Oxf). 2006 Jul;65(1):51-8. doi: 10.1111/j.1365-2265.2006.02545.x. Clin Endocrinol (Oxf). 2006. PMID: 16817819

9

Peroxisome proliferator-activated receptor gamma (PPAR) agonism reduces the insulin-stimulated increase in circulating interleukin-6 in GH replaced GH-deficient adults.

Krag MB, Rasmussen LM, Hansen TK, Frystyk J, Flyvbjerg A, Møller N, Jørgensen JO. Krag MB, et al. Clin Endocrinol (Oxf). 2009 Sep;71(3):363-8. doi: 10.1111/j.1365-2265.2008.03483.x. Epub 2008 Dec 3. Clin Endocrinol (Oxf). 2009. PMID: 19067726 Clinical Trial.

10

Hypothesis: Extra-hepatic acromegaly: a new paradigm?

Neggers SJ, Kopchick JJ, Jørgensen JO, van der Lely AJ. Neggers SJ, et al. Eur J Endocrinol. 2011 Jan;164(1):11-6. doi: 10.1530/EJE-10-0969. Epub 2010 Nov 2. Eur J Endocrinol. 2011. PMID: 21045065

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

259 results

Search Page